What does CUSIP 427746102 represent in this 13F holders report?

CUSIP 427746102 is the security identifier for HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock used to aggregate holder disclosures.

How many institutions held HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock in Q1 2022?

176 institutional investors reported HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock for Q1 2022. Use the holders table for investor-level position and value details.

- Common Stock (HRTX)

CUSIP: 427746102

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class: Equity / Common Stock
Shares outstanding: 182,615,507
Total 13F shares: 108,535,070
Share change: -9,219,216
Total reported value: $620,478,626
Put/Call ratio: 29%
Price per share: $5.72
Number of holders: 176
Value change: -$95,435,236
Number of buys: 90
Number of sells: 78

Quarterly Holders Quick Answers

What is CUSIP 427746102?
CUSIP 427746102 identifies HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2022
Previous quarter: Q4 2021

Recent filing periods for CUSIP 427746102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FRANKLIN RESOURCES INC	13F	Company	6.6%	11,967,465	$109,263,000	—	31 Dec 2021	13F
VANGUARD GROUP INC	13F	Company	5.3%	9,609,045	$87,730,000	—	31 Dec 2021	13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)	13F	Company	4.5%	8,275,000	$75,551,000	—	31 Dec 2021	13F
BAKER BROS. ADVISORS LP	13F	Company	4.5%	8,131,678	$74,242,000	—	31 Dec 2021	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	4.3%	7,782,928	$71,058,000	—	31 Dec 2021	13F
STATE STREET CORP	13F	Company	4.2%	7,692,411	$70,232,000	—	31 Dec 2021	13F
BlackRock Finance, Inc.	13F	Company	4.2%	7,682,201	$70,139,000	—	31 Dec 2021	13F
ArrowMark Colorado Holdings LLC	13F	Company	3.5%	6,405,865	$58,486,000	—	31 Dec 2021	13F
JPMORGAN CHASE & CO	13F	Company	3.4%	6,254,739	$57,105,000	—	31 Dec 2021	13F
PFM Health Sciences, LP	13F	Company	1.9%	3,512,348	$32,068,000	—	31 Dec 2021	13F
PALISADE CAPITAL MANAGEMENT, LP	13F	Company	1.7%	3,034,172	$27,702,000	—	31 Dec 2021	13F
Sofinnova Investments, Inc.	13F	Company	1.6%	2,933,351	$26,781,000	—	31 Dec 2021	13F
SUVRETTA CAPITAL MANAGEMENT, LLC	13F	Company	1.4%	2,486,340	$22,700,000	—	31 Dec 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	1.1%	1,918,410	$17,515,000	—	31 Dec 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.94%	1,711,608	$15,626,000	—	31 Dec 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.93%	1,692,919	$15,456,000	—	31 Dec 2021	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.9%	1,638,273	$14,957,000	—	31 Dec 2021	13F
ROTHSCHILD & CO ASSET MANAGEMENT US INC.	13F	Company	0.76%	1,379,846	$12,598,000	—	31 Dec 2021	13F
D. E. Shaw & Co., Inc.	13F	Company	0.74%	1,350,491	$12,330,000	—	31 Dec 2021	13F
C WorldWide Group Holding A/S	13F	Company	0.66%	1,202,069	$10,975,000	—	31 Dec 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.55%	1,004,798	$9,174,000	—	31 Dec 2021	13F
NORTHERN TRUST CORP	13F	Company	0.53%	961,690	$8,780,000	—	31 Dec 2021	13F
NORGES BANK	13F	Company	0.44%	808,960	$7,386,000	—	31 Dec 2021	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.44%	802,568	$7,327,000	—	31 Dec 2021	13F
Integral Health Asset Management, LLC	13F	Company	0.41%	750,000	$6,848,000	—	31 Dec 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.38%	696,257	$6,357,000	—	31 Dec 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.39%	720,869	$6,098,000	—	31 Dec 2021	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.33%	602,613	$5,502,000	—	31 Dec 2021	13F
Pekin Hardy Strauss, Inc.	13F	Company	0.31%	570,240	$5,206,000	—	31 Dec 2021	13F
Rafferty Asset Management, LLC	13F	Company	0.31%	561,277	$5,124,000	—	31 Dec 2021	13F
Woodline Partners LP	13F	Company	0.31%	557,799	$5,093,000	—	31 Dec 2021	13F
NEXPOINT ASSET MANAGEMENT, L.P.	13F	Company	0.27%	499,131	$4,557,000	—	31 Dec 2021	13F
KBC Group NV	13F	Company	0.26%	475,633	$4,343,000	—	31 Dec 2021	13F
CITIGROUP INC	13F	Company	0.24%	440,684	$4,023,000	—	31 Dec 2021	13F
SEI INVESTMENTS CO	13F	Company	0.22%	394,473	$3,599,000	—	31 Dec 2021	13F
DEUTSCHE BANK AG\	13F	Company	0.21%	388,630	$3,548,000	—	31 Dec 2021	13F
Orchard Capital Management, LLC	13F	Company	0.2%	366,004	$3,342,000	—	31 Dec 2021	13F
Caption Management, LLC	13F	Company	0.19%	349,110	$3,188,000	—	31 Dec 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.19%	345,232	$3,152,000	—	31 Dec 2021	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.18%	336,881	$3,076,000	—	31 Dec 2021	13F
UBS Group AG	13F	Company	0.17%	319,257	$2,915,000	—	31 Dec 2021	13F
Bank of New York Mellon Corp	13F	Company	0.16%	298,851	$2,729,000	—	31 Dec 2021	13F
Hennion & Walsh Asset Management, Inc.	13F	Company	0.16%	296,052	$2,703,000	—	31 Dec 2021	13F
MORGAN STANLEY	13F	Company	0.16%	292,148	$2,667,000	—	31 Dec 2021	13F
Apollo Management Holdings, L.P.	13F	Company	0.16%	283,859	$2,592,000	—	31 Dec 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.15%	266,488	$2,433,000	—	31 Dec 2021	13F
Jefferies Group LLC	13F	Company	0.14%	260,040	$2,374,165	—	31 Dec 2021	13F
OAK RIDGE INVESTMENTS LLC	13F	Company	0.12%	217,028	$1,982,000	—	31 Dec 2021	13F
Allianz Asset Management GmbH	13F	Company	0.12%	215,644	$1,972,000	—	31 Dec 2021	13F
Swiss National Bank	13F	Company	0.12%	213,700	$1,951,000	—	31 Dec 2021	13F

Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX) as of Q1 2022

As of 31 Mar 2022, HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX) was held by 176 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 108,535,070 shares. The largest 10 holders included STATE STREET CORP, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, BlackRock Inc., BAKER BROS. ADVISORS LP, ArrowMark Colorado Holdings LLC, JPMORGAN CHASE & CO, TANG CAPITAL MANAGEMENT LLC, PFM Health Sciences, LP, and PALISADE CAPITAL MANAGEMENT LLC/NJ. This page lists 176 institutional shareholders reporting positions in this security for the Q1 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2022 vs Q4 2021 Across Filers

Q4 2021 holders

192

Q1 2022 holders

176

Holder diff

-16

Investor	Q4 2021 Shares	Q1 2022 Shares	Share Diff	Share Chg %	Q4 2021 Value $	Q1 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.